Book a demo
Research & KnowledgeEvent: September 4, 2026

Manava Plus develops a testable experimental architecture for human brain organoids using clinical insights.

Published

Signal category

Research & Knowledge

Quote

Manava Plus turns that bet into a testable experimental architecture: 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 𝘄𝗶𝘁𝗵 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗼𝗻𝘁𝗲𝗻𝘁

Manava Plus team

Company

Manava Plus

Mankind. Augmented.

Industry
Medical Equipment Manufacturing
Location
Lugano, CH
Company size
17 employees

Manava Plus is pioneering revolutionary spinal cord and brain injury treatments, aiming to turn permanent disability into a temporary challenge. Our mission is to develop neural prostheses that restore disrupted circuits caused by spinal cord injury, allowing patients to walk and feel again We are working to realise Neural Control Interface technology integrating autologous spinal organoids on a microchip with AI control; aiming at personalized patients care that would empower people with neurological impairments to gain a new life.

Founded 2022

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.